Protalix BioTherapeutics, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Dec 2008 | — | — | $42.6M |
| Dec 2009 | — | — | $81.3M |
| Jun 2010 | — | — | $55.0M |
| Sep 2010 | — | — | $44.4M |
| Dec 2010 | $76.1M | $64.7M | $35.9M |
| Mar 2011 | — | — | $50.2M |
| Jun 2011 | $80.6M | $71.9M | $44.1M |
| Sep 2011 | $78.2M | $60.8M | $34.6M |
| Dec 2011 | $77.9M | $51.8M | $27.0M |
| Mar 2012 | $74.9M | $68.5M | $45.6M |
| Jun 2012 | $76.4M | $84.3M | $59.3M |
| Sep 2012 | $72.6M | $77.4M | $50.2M |
| Dec 2012 | $82.1M | $78.7M | $52.0M |
| Mar 2013 | $76.2M | $69.9M | $41.9M |
| Jun 2013 | $74.3M | $62.3M | $33.1M |
| Sep 2013 | $137.9M | $121.2M | $91.4M |
| Dec 2013 | $140.3M | $113.3M | $86.4M |
| Mar 2014 | $137.0M | $103.4M | $77.7M |
| Jun 2014 | $136.4M | $96.7M | $71.1M |
| Sep 2014 | $132.5M | $84.8M | $60.3M |
| Dec 2014 | $134.0M | $78.4M | $54.8M |
| Mar 2015 | $133.2M | $72.0M | $48.0M |
| Jun 2015 | $131.1M | $66.0M | $43.2M |
| Sep 2015 | $128.0M | $59.5M | $34.2M |
| Dec 2015 | $86.4M | $97.3M | $76.4M |
| Mar 2016 | $84.7M | $87.3M | $66.7M |
| Jun 2016 | $86.8M | $78.9M | $54.6M |
| Sep 2016 | $85.6M | $70.5M | $51.3M |
| Dec 2016 | $92.2M | $82.2M | $63.3M |
| Mar 2017 | $140.3M | $71.9M | $48.0M |
| Jun 2017 | $79.7M | $59.0M | $34.5M |
| Sep 2017 | $87.1M | $61.1M | $33.5M |
| Dec 2017 | $101.7M | $72.2M | $51.2M |
| Mar 2018 | $100.2M | $64.8M | $41.3M |
| Jun 2018 | $94.5M | $51.7M | $28.3M |
| Sep 2018 | $113.7M | $65.7M | $41.9M |
| Dec 2018 | $114.0M | $61.1M | $37.8M |
| Mar 2019 | $120.9M | $61.0M | $30.4M |
| Jun 2019 | $122.7M | $55.2M | $25.1M |
| Sep 2019 | $124.6M | $53.7M | $21.4M |
| Dec 2019 | $115.7M | $45.4M | $17.8M |
| Mar 2020 | $113.8M | $82.9M | $14.2M |
| Jun 2020 | $106.5M | $71.7M | $4.8M |
| Sep 2020 | $105.6M | $72.3M | $13.5M |
| Dec 2020 | $95.0M | $67.9M | $18.3M |
| Mar 2021 | $88.3M | $102.8M | $19.8M |
| Jun 2021 | $104.4M | $108.2M | $33.9M |
| Sep 2021 | $83.3M | $83.5M | $10.6M |
| Dec 2021 | $79.7M | $73.7M | $39.0M |
| Mar 2022 | $75.9M | $68.4M | $16.9M |
| Jun 2022 | $70.5M | $60.6M | $12.5M |
| Sep 2022 | $68.2M | $56.7M | $10.7M |
| Dec 2022 | $66.4M | $55.8M | $17.1M |
| Mar 2023 | $65.6M | $66.6M | $33.0M |
| Jun 2023 | $49.4M | $88.4M | $48.2M |
| Sep 2023 | $49.3M | $87.6M | $20.4M |
| Dec 2023 | $50.9M | $84.4M | $23.6M |
| Mar 2024 | $60.0M | $89.8M | $27.2M |
| Jun 2024 | $63.0M | $91.5M | $23.4M |
| Sep 2024 | $29.1M | $61.6M | $27.4M |
| Dec 2024 | $30.2M | $73.4M | $19.8M |
| Mar 2025 | $28.7M | $73.9M | $19.5M |
| Jun 2025 | $28.6M | $78.5M | $17.9M |
| Sep 2025 | $29.4M | $82.3M | $13.6M |
| Dec 2025 | $34.1M | $82.3M | $14.7M |
| Mar 2026 | $35.1M | $102.3M | $41.0M |
| Jun 2026 | $38.9M | $110.3M | $27.4M |